Merck's Keytruda meets dual primary endpoint in late-stage triple-negative breast cancer study
May 13 2021 - 8:29AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Merck (NYSE:MRK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Sep 2023 to Sep 2024